Code | Name | Scope Note |
---|---|---|
F1101102 | Burden of disease | |
F1101199 | Other health care system, industries and technologies n.e.c. | |
F1101121 | Assistive technology | |
F1101120 | Standards and calibration | |
F1101119 | Quality of life | |
F1101118 | Quality assurance of health instruments | |
F1101117 | Programme evaluation | |
F1101116 | Medical biotechnology | |
F1101115 | Innovative technology | |
F1101114 | Human resource development | sn: including technologies in attitude determination control instruments |
F1101113 | Home care services | |
F1101111 | Health rehabilitation service | |
F1101112 | Health technology assessments | |
F1101101 | Biomechanics | |
F1101103 | Continuous quality improvement | |
F1101104 | Delivery systems | |
F1101105 | Equity | |
F1101106 | Health care financing | |
F1101107 | Health information management | |
F1101108 | Health legislation | |
F1101109 | Health outcomes | |
F1101110 | Health policy analysis |
Code | Name |
---|---|
F1101499 | Other pharmacy n.e.c. |
F1101413 | Social pharmacy |
F1101412 | Pharmacokinetics |
F1101411 | Pharmacognosy |
F1101410 | Pharmaco-genomic |
F1101409 | Pharmaco-economics |
F1101408 | Pharmaceutical technology |
F1101407 | Pharmaceutical biotechnology |
F1101406 | Nuclear pharmacy |
F1101405 | Medicinal chemistry |
F1101404 | Drug discovery |
F1101403 | Clinical pharmacy |
F1101402 | Biopharmacy |
F1101401 | Bioassay methods |